BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6099378)

  • 1. Endocrine studies on ovarian androblastomas (Sertoli-Leydig tumors).
    Munemura M; Inoue S; Himeno R; Koyama N; Mizumoto J; Maeyama M; Iwamasa T
    J Endocrinol Invest; 1984 Dec; 7(6):615-22. PubMed ID: 6099378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endocrine profile and electron microscopic study of ovarian androblastoma].
    Inoue S; Fukuda O; Koyama N; Furuki Y; Munemura M; Maeyama M; Mizumoto J; Miyayama Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1155-62. PubMed ID: 6096462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine profile of an ovarian androblastoma.
    Munemura M; Nakamura T; Matsuura K; Maeyama M; Iwamasa T
    Obstet Gynecol; 1982 Jun; 59(6 Suppl):100S-4S. PubMed ID: 6283443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and hormonal characteristics in a case of ovarian arrhenoblastoma.
    Tita P; Spina A; Briguglia G; Magro A; Gallo D; Finocchiaro C; Padova G; Pezzino V
    J Endocrinol Invest; 1996; 19(7):484-7. PubMed ID: 8884544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hormone pattern in a case of arrhenoblastoma.
    Toscano V; Adamo MV; Boscherini B; Pasquino AM; Herlitzka L; Petrangeli E; Sciarra F
    Eur J Pediatr; 1981 May; 136(2):203-6. PubMed ID: 6262084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo endocrine studies in adrenal rest tumor of ovary.
    Parker CR; Servy E; McDonough PG; Mahesh VB
    Obstet Gynecol; 1974 Sep; 44(3):327-32. PubMed ID: 4277531
    [No Abstract]   [Full Text] [Related]  

  • 7. Peripheral and ovarian venous concentrations of various steroid hormones in virilizing ovarian tumors.
    Meldrum DR; Abraham GE
    Obstet Gynecol; 1979 Jan; 53(1):36-43. PubMed ID: 215947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical and biochemical analysis of a human Sertoli-Leydig cell tumor: autonomous steroid production characteristic of ovarian theca cells.
    Sawetawan C; Rainey WE; Word RA; Carr BR
    J Soc Gynecol Investig; 1995; 2(1):30-7. PubMed ID: 9420846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine features of an adrenal-like tumor of the ovary.
    Adashi EY; Rosenwaks Z; Lee PA; Jones GS; Migeon CJ
    J Clin Endocrinol Metab; 1979 Feb; 48(2):241-5. PubMed ID: 155074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine studies in the arrhenoblastoma.
    Mahesh VB; McDonough PG; Deleo CA
    Am J Obstet Gynecol; 1970 May; 107(2):183-7. PubMed ID: 4315088
    [No Abstract]   [Full Text] [Related]  

  • 11. Endocrine studies during stimulation-suppression in hirsutism.
    Samaan NA; Gates RB; Hickey RC; Rutledge FH
    Obstet Gynecol; 1975 Jul; 46(1):104-8. PubMed ID: 168518
    [No Abstract]   [Full Text] [Related]  

  • 12. Sertoli-Leydig cell tumour of the ovary--a rare cause of virilization after menopause.
    Hansen TP; Sørensen B
    APMIS; 1993 Sep; 101(9):663-6. PubMed ID: 8240784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and resection of an oral contraceptive-suppressible Sertoli-Leydig cell tumor with preservation of fertility and a 7-year follow-up.
    Haning RV; Loughlin J; Shapiro SS
    Obstet Gynecol; 1989 May; 73(5 Pt 2):901-5. PubMed ID: 2523030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human follicle-stimulating hormone administration increases testosterone production in men, possibly by a Sertoli cell-secreted nonsteroid factor.
    Levalle O; Zylbersztein C; Aszpis S; Aquilano D; Terradas C; Colombani M; Aranda C; Scaglia H
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3973-6. PubMed ID: 9814477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of virilizing adrenal tumors in hirsute women.
    Derksen J; Nagesser SK; Meinders AE; Haak HR; van de Velde CJ
    N Engl J Med; 1994 Oct; 331(15):968-73. PubMed ID: 8084355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone/androstenedione ratio in the evaluation of women with ovarian androgen excess.
    Wiebe RH; Morris CV
    Obstet Gynecol; 1983 Mar; 61(3):279-84. PubMed ID: 6296743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virilising ovarian tumour: a case associating a Sertoli-Leydig cell tumour and a Brenner tumour.
    Persechini ML; Motton S; Leguevaque P; Donadille F; Escourrou G; Vierasu B; Hamdi S; Bennet A; Caron P
    Gynecol Endocrinol; 2011 May; 27(5):345-50. PubMed ID: 20569103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucinous adenofibroma of the ovary: case report of the endocrinologic findings.
    Tohya T; Mizutani H; Katabuchi H; Miyazaki K; Okamura H
    Gynecol Oncol; 1994 Aug; 54(2):218-21. PubMed ID: 8063250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone studies in a case of virilisation due to ovarian tumour.
    Fleetwood JA; Watson MJ; Wastell HJ; Weddell A
    Ann Clin Biochem; 1985 Sep; 22 ( Pt 5)():498-501. PubMed ID: 2998262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.